Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate COmpared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in ART-Naïve People Living With HIV and Overweight or Obesity

NCT07075146 is registered in ClinicalTrials.gov with José Antonio Mata Marín as lead sponsor.

NCT NCT07075146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07075146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate COmpared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in ART-Naïve People Living With HIV and Overweight or Obesity
Lead sponsor
José Antonio Mata Marín
Phase
Phase 3
Overall status
Recruiting
Start date
May 5, 2025
Completion date
August 1, 2028
Enrollment
306 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv - human immunodeficiency virus, obesity, overweight and/or obesity